WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2026 Issue has been successfully launched on FEBRUARY 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR February 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

ASSOCIATION BETWEEN ABNORMAL PAP SMEAR AND HPV RESULTS AMONG SYMPTOMATIC WOMEN ATTENDING AL-ELWIYA MATERNITY TEACHING HOSPITAL (TUMOR WOMEN CENTER)/BAGHDAD

Israa Ihsan Ali*, Besmah M. Ali and Najim Al-Khalidy

ABSTRACT

Background: cervical cancer is ranked the fourth common cancer among women, low- and middle-income countries account for 90% of cervical cancer mortality. It is the second largest cause of death for women in the Caribbean, three times higher than in North America and anticipated to rise 45% by 2030. This study analyzed the correlation between HPV type and Papanicolaou (Pap)-stained cervical smear cytological findings in the uterine cervix. Method: The study conducted at Al-Elwiya Maternity Teaching Hospital analyzed the correlation between HPV infection and Pap smear results in symptomatic women. Participants underwent HPV typing and cytological examination using the Papanicolaou method. Statistical analysis assessed associations between HPV status and cytological findings. Ethical approval and informed consent were secured, ensuring participant confidentiality. Results: The study population comprised mostly women aged 30-49 years, all married and primarily housewives. Pap smear results indicated 54% NILM, 30% ASCUS, and 16% LISL, with no significant difference in HPV positivity across these categories. HPV infection was detected in 20% of participants. These findings suggest the necessity for comprehensive cervical cancer screening, integrating both Pap smear and HPV testing, to effectively identify at-risk women. Conclusion: In the study, most symptomatic women at Al-Elwiya Maternity Teaching Hospital were 30-49 years old, married, housewives with high parity. Pap smear findings indicated 54% NILM, 30% ASCUS, and 16% LISL with no significant HPV positive difference. 20% of subjects had HPV, suggesting a low prevalence. The findings emphasise the need for comprehensive cervical cancer screening programmes that include cytological and HPV testing to identify and manage at-risk women. Similar findings show the necessity for focused screening in symptomatic patients.

[Full Text Article] [Download Certificate]